Absence of Connexin 40 gene polymorphism, as a marker of undetected atrial fibrillation in patients with unexplained cerebral ischemic events

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 16, Issue 5, 2009, Pages 616-620

  Chaldoupi, Sevasti Maria ^a   Soedamah Muthu, Sabita S ^a,b   Regieli, Jakub ^a   Werf, Christian Van De ^a   Nelen, Marcel ^a   Van Der Smagt, Jasper J ^a   Algra, Ale ^a   Hauer, Richard N W ^a   Doevendans, Pieter A ^a   Loh, Peter ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Atrial fibrillation; Cerebral ischemia; Genetics

Indexed keywords

CONNEXIN 40;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; GENOTYPE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 72449144173     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32832da03a     Document Type: Article

References (27)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006; 27:1979-2030. (Pubitemid 44313588)
2. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, et al. The natural history of lone atrial fibrillation. A populationbased study over three decades. N Engl J Med 1987; 317:669-674.
3. Phillips SJ. Is atrial fibrillation an independent risk factor for stroke? Can J Neurol Sci 1990; 17:163-168.
4. Chesebro JH, Fuster V, Halperin JL. Atrial fibrillation-risk marker for stroke. N Engl J Med 1990; 323:1556-1558.
5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22:983-988.
6. Firouzi M, Ramanna H, Kok B, Jongsma HJ, Koeleman BP, Doevendans PA, et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004; 95:e29-e33.
7. Juang JM, Chern YR, Tsai CT, Chiang FT, Lin JL, Hwang JJ, et al. The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol 2007; 116:107-112.
8. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der GY. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999; 15:773-781.
9. Kannel WB,Wolf PA,Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 1983; 250:2942-2946.
10. Hunkapiller T, Hood L. LIMS and the Human Genome Project. Biotechnology (NY) 1991; 9:1344-1345.
11. Groenewegen WA, Firouzi M, Bezzina CR, Vliex S, van Langen I, Sandkuijl L, et al. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ.Res 2003; 92:14-22.
12. Yuan Z, Bowlin S, Einstadter D, Cebul RD, Conners AR Jr, Rimm AA. Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries. Am J Public Health 1998; 88:395-400.
13. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41.
14. Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 1986; 17:622-626.
15. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke 1983; 14:664-667.
16. Toda G, Akiyama K, Sakuragawa K, Iliev II, Hayano M, Yano K. Thromboembolic complication in atrial fibrillation in a long-term follow-up - the relationship with underlying disease, type of atrial fibrillation, and antithrombotic therapy. Jpn Circ J 1998; 62:255-260.
17. Scardi S, Mazzone C, Pandullo C, Goldstein D, Poletti A, Humar F. Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up. Am Heart J 1999; 137:686-691.
18. Nieuwlaat R, Dinh T, Olsson SB, Camm AJ, Capucci A, Tieleman RG, et al. Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 2008; 29:915-922.
19. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000; 35:183-187.
20. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 1990; 21:47-51.
21. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990; 16:377-380.
22. Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997; 29:106-112.
23. Canepa-Anson R,Williams M, Marshall J, Mitsuoka T, Lightman S, Sutton R. Mechanism of polyuria and natriuresis in atrioventricular nodal tachycardia. Br Med J (Clin Res Ed) 1984; 289:866-868.
24. Boykin J, Cadnapaphornchai P, McDonald KM, Schrier RW. Mechanism of diuretic response associated with atrial tachycardia. Am J Physiol 1975; 229:1486-1491.
25. Lavy S, Stern S. Transient neurological manifestations in cardiac arrhythmias. J Neurol Sci 1969; 9:97-102.
26. Lavy S, Stern S, Melamed E, Cooper G, Keren A, Levy P. Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke 1980; 11:35-38. (Pubitemid 10160374)
27. Petersen P, Kastrup J, Videbaek R, Boysen G. Cerebral blood flow before and after cardioversion of atrial fibrillation. J Cereb Blood Flow Metab 1989; 9:422-425. (Pubitemid 19134820)